Results

Total Results: 1,544 records

Showing results for "drug".

141. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 - Mifepristone, a drug for psychotic major depression (PMD), a condition for which no U.S. … administration and is known to be a street drug of abuse. … Research suggests new drug targets for depression. … Food and Drug Administration (FDA) [accessed 2012 Mar 15]. [2 p]. … Washington (DC): Drug Enforcement Administration, U.S.

142. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Drug Enforcement Administration. … The drug was subsequently studied for its potential to reduce IBS symptoms, such as diarrhea. … Food and Drug Administration (FDA) for treating diarrhea-predominant IBS. … Some experts believe that concerns about overuse of antibiotics might limit the use of the drug. … Food and Drug Administration (FDA); 2015 May 27 [accessed 2015 Jun 03]. [5 p].

143. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
     April 01, 2020 - cognitive impairment; biomarker accuracy for Alzheimer’s disease (AD) in dementia; and effects of CATD drug … Few trials directly compared different drug treatments. … Future BPSD trials also should directly compare drug and nondrug treatment strategies, and drug trials … Food & Drug Administration. U.S. … Food & Drug Administration.

144. Pharmacotherapy for Adults with Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
     September 01, 2017 - 16 97 Anton61 2011 naltrexone, acamprosate, gabapentin Medium 150 Largest for drug only 3 drug … Medium 150 Largest for drug 29 88 Naranjo69 1995 citalopram High 150 Largest for drug 64 149 Kranzler70 … Drug and alcohol dependence. 2013;133(2):440-446. 21. … Drug and alcohol dependence. 2013;133(2):754-758. 26. … The American journal of drug and alcohol abuse. 2017;43(3):324-331. 31.

145. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - Adverse drug reactions: definitions, diagnosis, and management. … Center for Drug Evaluation and Research. … Adverse drug reactions: keeping up to date. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

146. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - Adverse drug reactions: definitions, diagnosis, and management. … Center for Drug Evaluation and Research. … Adverse drug reactions: keeping up to date. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

147. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - J Stud Alc Drug Dependence. 2012;73 (6):991-997 Thank you for the comment. … longitudinal care coordinated by a primary care clinician with no CCM for people with alcohol or drug … As I said before, if they take the drug at the right dose, it is unlikely that drinking will occur. … J Stud Alc Drug Dependence. 2012;73 (6):991-997. 5. Dunbar JL, Tumcliff RZ, Dong Q, et al. … Only if a trial recruited more patients that responded to drug A than drug B would you get a difference

148. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
     May 01, 2024 - Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events ........ … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults 9a. … involving CDSS to reduce medication errors and adverse drug events. … Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events 1a. … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults 9a.

149. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April … Introduction Comparative Effectiveness Review (CER) #55, Drug Therapy for Rheumatoid Arthritis in … This drug is not a biologic. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update. … Risk did not differ significantly by specific drug.

150. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April … Introduction Comparative Effectiveness Review (CER) #55, Drug Therapy for Rheumatoid Arthritis in … This drug is not a biologic. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update. … Risk did not differ significantly by specific drug.

151. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Opioid abuse is one of the most common forms of prescription drug abuse. … The company submitted a new drug application to the U.S. … Food and Drug Administration (FDA) in October 2012. … recommend approval; however, on April 30, 2013, the company announced that FDA did not approve the drug … If new trials are needed, resubmission of a new drug application would be delayed for a considerable

152. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … preliminary phase III data for drugs (or preliminary late-phase clinical trial data for off-label drug … Food and Drug Administration has not approved an AD-treating drug since galantamine in 2004. … We continue to monitor early developments of new drug candidates and diagnostics in this priority area … This drug, in various formulations, is approved and widely used to manage diabetes indications; no major

153. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - drug- name=qsymia. … drug-name=xenical http://www.goodrx.com/xenical?drug-name=xenical http://www.goodrx.com/belviq? … drug-name=belviq http://www.goodrx.com/belviq?drug-name=belviq http://www.goodrx.com/contrave? … drug-name=contrave http://www.goodrx.com/contrave?drug-name=contrave http://www.goodrx.com/qsymia? … drug-name=qsymia http://www.goodrx.com/qsymia?drug-name=qsymia 20 82. Aetna.

154. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
     June 01, 2022 - Reviews, PsycINFO®, and Scopus from September 2, 2021 to December 30, 2021.We also searched Food and Drug … Placebo From the previous report, NSAIDs as a drug class, compared with placebo, resolved pain at … No change in SOE supporting the effect of NSAIDs as a drug class vs. … analyses Abbreviations: KQ = Key Question; mg = milligram; NSAID = nonsteroidal anti-inflammatory drug … Therapy] 24 exp Vomiting/dt [Drug Therapy] 25 (((drug* or agent* or medication*) adj3 (nausea or

155. Ced-Topic-Refinement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
     November 01, 2022 - Framework for FDA's Real-World Evidence Program US Food & Drug Administration. … and Biological Products US Food & Drug Administration. … Guidance for Industry US Food & Drug Administration. … and Biological Products US Food & Drug Administration. … Data Standards for Drug and Biological Product Submissions Containing Real-World Data US Food & Drug

156. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - This drug is injected. … FDA approves Qsymia, a weight-loss drug. [internet]. … Food and Drug Administration (FDA); 2014 Jun 17. 78 p. … Food and Drug Administration (FDA); 2014 Jun 17. 89 p. … Food and Drug Administration.

157. S149 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
     October 01, 2007 - that uses subclassification on a longitudinal pro- pensity score to compare outcomes between a new drug … We explored the usefulness of these methods in our study of a new drug for treatment of type 2 diabetes … The median date for first filling a pre- scription for this drug was mid-October 2005. … Because the drug was only recently approved, we had limited follow-up time. … Additionally, when studying a new drug, it is even less clear what are the predictors of use of the drug

158. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - United States Food and Drug Administration. FDA Statement on coronary drug-eluting stents. … United States Food and Drug Administration. … Update to FDA statement on coronary drug-eluting stents. … Effectiveness and Safety of Drug- Eluting Stents in Ontario. … : An Observational Study of Drug-Eluting Versus Bare-Metal Stents.

159. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - Does product discuss harm and benefit of treatment with the drug? … Guidelines for Diagnosis and Management of Osteoporosis in Canada (2002) Osteoporosis Canada Website, “Drug … increased risk of cardiovascular disease, their families and the public Canada Osteoporosis Canada “Drug … www.osteoporosis.ca Osteoporosis Canada: About Osteoporosis--Drug Treatments Appropriate … comparison of alternatives Yes, both discussed, but not in detail Yes, Explore with doctor and find best drug

160. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
     January 01, 2013 - Pharmacoepidemiol Drug Saf 2006 May;15(5):291-303. … receiving drug B (comparison), as exposure to A is largely independent of exposure to B. … Pharmacoepidemiol Drug Saf 2006 May;15(5):291-303. … Paradoxical relations of drug treatment with mortality in older persons. … Dose/Intensity of Drug Comparison It is important to appreciate the effects of dose on outcomes.